1. Stocks
    2. /
  2. Moderna (NASDAQ: MRNA)
    3. /

Moderna (NASDAQ: MRNA) Share Price and News

$51.28 $-0.10 (-0.2%) 24 March 2026 at 7:00:00 am AEDT

Moderna Chart and Price Data

About Moderna

Last updated 24-03-2026, 07:00:00am AEDT
Current Price $51.28
Change $-0.10 (-0.2%)
Close Price $51.28
Open Price $51.23
Bid $51.13
Ask $51.19
Day Range $50.19 - $52.55
Year Range $22.28 - $59.55
Volume 5,975,127
Average Volume 11,425,051
Market Cap $20,291,987,955.00
Earnings Per Share $-7.26

Moderna (NASDAQ: MRNA)
Latest News

Vaccine vials sitting on top of a pile of US cash
International Stock News

The most popular coronavirus stock may lose half its value by 2023

| Sean Williams

This as-of-now unstoppable COVID-19 stock might be one of the worst investments going forward.

Read more »

Doctors and medical specialists look at the results of a drug trial, as the race for a coronavirus vaccine continues
International Stock News

Is Moderna stock a hold?

| Cory Renauer

An analyst downgrade put one of the year's top-performing stocks under pressure.

Read more »

vials of medication labelled with COVID-19 vaccine stickers
Share Market News

CSL (ASX:CSL) share price on watch after hints of 'far more robust' vaccine

| Bernd Struben

Australian global biotech giant CSL Limited didn't win the sprint for a coronavirus vaccine. But it may lead the marathon.

Read more »

travel asx share price represented by suitcase wearing covid mask
Share Gainers

Which ASX travel shares performed the best in November? 

| Lina Lim

On the back of vaccine hopes and reopening borders, which ASX travel shares performed the best in November? We take…

Read more »

doctor holding covid-19 vaccine bottle
International Stock News

3 key advantages Moderna holds over Pfizer and AstraZeneca

| Keith Speights

They could add up to make Moderna a much bigger winner for investors than either of the two big pharma…

Read more »

investor of asx shares holding up hand to say no
Share Market News

Why Platinum Asset's healthcare fund doesn't own CSL (ASX:CSL) shares

| Bernd Struben

CSL is the fourth largest company trading on the ASX 200. But Platinum Asset's healthcare fund doesn't own any CSL…

Read more »

Doctor holding small world globe in one hand and a Covid vaccine needle in the other
International Stock News

Why AstraZeneca's potential vaccine is more exciting than you think

| Jason Hawthorne

Investors are missing the big picture in the drugmaker's vaccine announcement.

Read more »

Cash piled up in the middle of a bear trap symbolising risky investments
International Stock News

Why Moderna Is Less Risky Than You Think

| Manali Bhade

Its coronavirus vaccine will likely be successful; its technology has huge potential; and the company has a healthy balance sheet.

Read more »

small figure representing ASX shares with cape and shield fighting coronavirus
Share Gainers

With the Moderna (NASDAQ:MRNA) share price blasting up, have the forward-looking markets got it right?

| Bernd Struben

The Moderna (NASDAQ: MRNA) share price is going gangbusters as the world awaits results of its COVID-19 vaccine trial. Let's…

Read more »

asx investor daydreaming about US shares
Share Market News

Here are the US shares that CommSec customers are buying

| Sebastian Bowen

Boeing (NYSE: BA), Pfizer (NYSE: PFE) and Tesla (NASDAQ: TSLA) were among the most traded US shares on the CommSec…

Read more »

vials of medication labelled with COVID-19 vaccine stickers
International Stock News

Here's why Moderna's coronavirus vaccine could outsell Pfizer's

| Alex Carchidi

Moderna's candidate is cool with being kept at warmer temperatures.

Read more »

success, high flyer, win, challenge
Share Market News

Dow Jones hits new record highs. Are ASX 200 shares next?

| Bernd Struben

The Dow Jones just hit new all-time highs. ASX 200 shares are still 9% below their record highs, but that…

Read more »

Profile

since

Note